Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Indian Journal of Cancer"" wg kryterium: JN


Tytuł:
Making inroads of radiotherapy in gallbladder cancer.
Autorzy:
Talapatra K; Department of Radiation Oncology, Nanavati Max Super Speciality Hospital, Mumbai, Maharashtra, India.
Lewis S; Department of Radiotherapy and Oncology, Kasturba Medical College, Manipal, Karnataka, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 447-448. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Gallbladder Neoplasms*/radiotherapy
Radiation Oncology*
Humans
Czasopismo naukowe
Tytuł:
Grossing and reporting of radical prostatectomy specimens: An evidence-based approach.
Autorzy:
Rao BV; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
Soni S; Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India.
Kulkarni B; Kokilaben Dhirubhai Ambani Hospital and Research Centre, Mumbai, Maharashtra, India.
Bindhu MR; Amrita Institute of Medical Sciences, Kochi, Kerala, India.
Ambekar A; Apollo Hospitals, Navi Mumbai, Maharashtra, India.
Midha D; Tata Medical Centre Kolkata, West Bengal, India.
Kaushal S; A.I.I.M.S, New Delhi, India.
Patil S; Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India.
Jagdale R; Shri Siddhivinayak Ganapati Cancer Hospital, Miraj, Maharashtra, India.
Sundaram S; Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Kumar RM; Christian Medical College, Vellore, Tamil Nadu, India.
Desai S; Department of Pathology, Tata Medical Centre, Mumbai, Maharashtra, India.
Menon S; Department of Pathology, Tata Medical Centre, Mumbai, Maharashtra, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 449-457. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate*/surgery
Prostatic Neoplasms*/surgery
Male ; Humans ; Prostatectomy/methods ; Biopsy ; Palliative Care
Czasopismo naukowe
Tytuł:
CD47 expression in urothelial carcinoma and its correlation with histopathological findings.
Autorzy:
Çoban G; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Yıldız P; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Şahin N; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Ersöz C; Department of Urology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Toprak A; Department of Biostatistics, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Ünver N; Department of Pathology, Yedikule Pulmonary Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey.
Elagöz Ş; Department of Pathology, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 458-463. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Carcinoma, Transitional Cell*/surgery
Urinary Bladder Neoplasms*/pathology
Carcinoma, Papillary*/pathology
Male ; Female ; Humans ; CD47 Antigen ; Urinary Bladder/pathology
Czasopismo naukowe
Tytuł:
Prevalence, distribution, and risk markers for the development of gonadal germ cell tumors in patients with certain types of disorders of sexual differentiation with Y chromosome - A retrospective study.
Autorzy:
Das DV; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Jabbar PK; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Gomez R; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Nambisan B; Department of Obstetrics and Gynecology, Government Medical College, Thiruvanathapuram, Kerala, India.
Bhuvitha MS; Department of Pathology, Government Medical College, Thiruvanathapuram, Kerala, India.
Nair A; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Jayakumari C; Department of Endocrinology, Government Medical College, Thiruvanathapuram, Kerala, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 464-474. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Dysgerminoma*/pathology
Neoplasms, Germ Cell and Embryonal*/epidemiology
Neoplasms, Germ Cell and Embryonal*/genetics
Ovarian Neoplasms*/pathology
Female ; Humans ; Adolescent ; Retrospective Studies ; Sex Differentiation ; Prevalence ; Y Chromosome/pathology
Czasopismo naukowe
Tytuł:
Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Autorzy:
Chandy RG; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Thomas V; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Sebastian A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Mani T; Department of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India.
Thomas A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Joel A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Ram TS; Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Peedicayil A; Department of Gynaecologic Oncology, Christian Medical College, Vellore, Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 475-485. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/drug therapy
Humans ; Female ; Carcinoma, Ovarian Epithelial ; Proportional Hazards Models ; Neoadjuvant Therapy/adverse effects ; Chemotherapy, Adjuvant ; Cytoreduction Surgical Procedures/adverse effects ; Hospitals ; Retrospective Studies ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
Autorzy:
Kathrotiya M; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Radhakrishnan V; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Bhave SJ; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Nag A; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Arora N; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India.
Roychoudhry M; Department of Clinical Hematology and HCT, Nursing Division, Tata Medical Center, Kolkata, West Bengal, India.
Parihar M; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India.
Mishra D; Laboratory Hematology and Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India.
Nair R; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Chandy M; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Kumar J; Departments of Clinical Hematology and HCT, Tata Medical Center, Kolkata, West Bengal, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 486-492. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/diagnosis
Multiple Myeloma*/drug therapy
Humans ; Bortezomib/therapeutic use ; Induction Chemotherapy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.
Autorzy:
Jaipuria J; Amity Centre for Cancer Epidemiology and Cancer Research, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
Jain A; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Gupta S; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Sadasukhi N; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Kasaraneni P; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Singh A; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Gupta K; Catalyst Clinical Services Pvt. Ltd., New Delhi, India.
Sharma G; Amity Centre for Cancer Epidemiology and Cancer Research, Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India.
Talwar V; Medical Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Rawal SK; Uro-Oncology Division, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, Sector - 5, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 493-500. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/pathology
Antineoplastic Agents*/adverse effects
Kidney Neoplasms*/pathology
Adult ; Humans ; Sunitinib/therapeutic use ; Indoles/adverse effects ; Pyrroles/adverse effects ; Treatment Outcome ; Disease-Free Survival ; Retrospective Studies
SCR Disease Name:
Clear-cell metastatic renal cell carcinoma
Czasopismo naukowe
Tytuł:
A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma.
Autorzy:
Paikaray SK; All India Institute of Medical Sciences, New Delhi, India.
Gogia A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Biswas AA; Department of Radiation Oncology, All India Institute of Medical Sciences, AIIMS, New Delhi, India.
Vishnubhatla S; Department of Biostatistics, AIIMS, New Delhi, India.
Mallick S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 501-504. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Lymphoma, Follicular*/drug therapy
Lymphoma, Follicular*/pathology
Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bendamustine Hydrochloride/therapeutic use ; Lenalidomide/therapeutic use ; Rituximab/therapeutic use ; Adult
Czasopismo naukowe
Tytuł:
Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country.
Autorzy:
Sharma RK; Department of Medical Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.
Gogia A
Deo S
Sharma D
Mathur S
Sagiraju HKR
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 505-511. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/pathology
Female ; Humans ; Neoadjuvant Therapy/adverse effects ; Retrospective Studies ; Developing Countries ; Antineoplastic Combined Chemotherapy Protocols ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Chemotherapy, Adjuvant ; Recurrence
Czasopismo naukowe
Tytuł:
The different prognostic factors between metastatic and nonmetastatic disease of esophageal neuroendocrine carcinoma.
Autorzy:
Zhong L; Department of Medical Oncology, Huzhou Central Hospital, Affiliated Central Hospital HuZhou University, Zhejiang, China.
Pan Y
Han S
Qi Q
Liao H
Jiang Y
Shen J
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 512-520. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Neuroendocrine*/pathology
Esophageal Neoplasms*/surgery
Humans ; Aged ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Autorzy:
Garg M; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India.
Abrol P; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India.
Gupta N; Department of Peadiatrics, PGIMS, Rohtak, Haryana, India.
Bharti S; Department of Pathology, Govt. Medical College, Sector 32, Chandigarh, India.
Nadda A; Department of Community Medicine, PGIMS, Rohtak, Haryana, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 521-527. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Marrow*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Humans ; Child ; Tertiary Care Centers ; Prognosis ; India/epidemiology ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł:
Quality of life and shoulder function among oral cancer patients treated with selective neck dissection: A cross-sectional study.
Autorzy:
Karthikeyan GR; Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India.; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Venkatramanaiah C; Department of Anatomy, Bharath Medical College and Hospital, Chennai, Tamil Nadu, India.
Balasubramaniyam B; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Aiyathurai M; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Velu D; Department of Oral and Maxillo-Facial Surgery, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Indrapriyadharshini K; Public Health Dentistry, Karpaga Vinayaga Institute of Dental Sciences, GST Road, Chinnakolambakam, Palayanur (PO), Chengalpattu (District), Tamil Nadu, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 528-533. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Head and Neck Neoplasms*/etiology
Mouth Neoplasms*/surgery
Mouth Neoplasms*/etiology
Humans ; Shoulder/surgery ; Neck Dissection/adverse effects ; Quality of Life ; Cross-Sectional Studies
Czasopismo naukowe
Tytuł:
Clinicopathologic features and risk factors associated with oral squamous cell carcinoma (OSCC): A comprehensive descriptive study analyzing the burden of OSCC in a tertiary-level hospital in North Kerala, India.
Autorzy:
Thankappan S; Department of Oral Medicine and Radiology, Govt. Dental College, Calicut, Kerala, India.
Nedumpillil S; Department of Oral Pathology and Microbiology, Govt. Dental College, Calicut, Kerala, India.
Thomas V; Department of Oral Medicine and Radiology, Govt. Dental College, Calicut, Kerala, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 534-541. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Mouth Neoplasms*/pathology
Head and Neck Neoplasms*/complications
Humans ; Squamous Cell Carcinoma of Head and Neck/epidemiology ; Squamous Cell Carcinoma of Head and Neck/complications ; Prospective Studies ; Risk Factors ; India/epidemiology ; Tertiary Care Centers
Czasopismo naukowe
Tytuł:
Incidental appendiceal neoplasms: Single-centre results.
Autorzy:
Ozdemir H; Haydarpasa Numune Training and Research Hospital, General Surgery Department, Istanbul, Turkey.
Ozdemir ZU
Gul MO
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 542-547. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Appendiceal Neoplasms*/diagnosis
Appendiceal Neoplasms*/surgery
Appendiceal Neoplasms*/pathology
Appendicitis*/diagnosis
Appendicitis*/surgery
Appendicitis*/pathology
Neuroendocrine Tumors*/diagnosis
Humans ; Retrospective Studies ; Appendectomy/methods
Czasopismo naukowe
Tytuł:
Association of preoperative serum adipokines, insulin, and sex steroid hormones with breast cancer risk in the Indian women.
Autorzy:
Dhiman D; Lady Hardinge Medical College, New Delhi, India.; Dr. Y.S. Parmar Govt. Medical College, Nahan, Himachal Pradesh, India.
Kumar A; Institute of Biotechnology, HiLIFE, University of Helsinki, Finland.
Shukla S; Lady Hardinge Medical College, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 548-555. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/epidemiology
Breast Neoplasms*/complications
Insulin Resistance*
Humans ; Female ; Leptin ; Adipokines ; Insulin ; Adiponectin ; Obesity/complications ; Body Mass Index ; Testosterone ; Gonadal Steroid Hormones ; Triglycerides
Czasopismo naukowe
Tytuł:
Synchronous occurrence of medullary and papillary thyroid cancer and survival rates.
Autorzy:
Akgun E; Department of Nuclear Medicine, Yuksek Ihtisas Hospital, Kirikkale, Turkey.
Sager S; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Beytur F; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Nazari A; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Ozturk T; Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Teksoz S; Department of General Surgery, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Sonmezoglu K; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 556-561. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Papillary*/pathology
Thyroid Neoplasms*/pathology
Carcinoma, Neuroendocrine*
Humans ; Thyroid Cancer, Papillary ; Calcitonin ; Survival Rate ; Retrospective Studies
SCR Disease Name:
Thyroid cancer, medullary
Czasopismo naukowe
Tytuł:
Apatinib plus drug-eluting bead transarterial chemoembolization as bridging therapy to surgical resection displays an acceptable efficacy and safety profile in hepatocellular carcinoma patients.
Autorzy:
Yan J; Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.
Sun Y; Department of Interventional Radiology, Shanxi Provincial People's Hospital, Taiyuan, China.
Fan D; Department of Hepatobiliary Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.
Mu W; Department of General Surgery, Shanxi Hospital of Integrated Traditional and Western Medicine, Taiyuan, China.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2023 Oct 01; Vol. 60 (4), pp. 562-569. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Chemoembolization, Therapeutic*
Pyridines*
Humans ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies